The two-step approach to allogeneic hematopoietic stem cell transplantation

The two-step approach to allogeneic hematopoietic stem cell transplantation

Allogeneic hematopoietic stem cell transplantation (HSCT) provides the only potentially curative option for multiple hematological conditions. However, allogeneic HSCT outcomes rely on an optimal balance of effective immune recovery, minimal graft-versus-host disease (GVHD), and lasting control of d...

Full description

Bibliographic Details
Main Authors:	Sikemi Ibikunle, Dolores Grosso, Usama Gergis
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-09-01
Series:	Frontiers in Immunology
Subjects:	two-step approach haploidentical matched related stem cell transplantation cyclophosphamide tolerization
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1237782/full

Similar Items

Post-transplant cyclophosphamide or cell selection in haploidentical allogeneic hematopoietic cell transplantation?
by: Razan Mohty, et al.
Published: (2024-12-01)

Haploidentical Hematopoietic Stem Cell Transplantation Followed by ‘Post-Cyclophosphamide’: The Future of Allogeneic Stem Cell Transplant
by: Samuel Cytryn, et al.
Published: (2020-04-01)

Intensified conditioning regimen with fludarabine combined with post-transplantation cyclophosphamide for haploidentical allogeneic hematopoietic stem cell transplantation in children with high-risk acute leukemia
by: Junjie Cao, et al.
Published: (2023-12-01)

Real‐world experience: Introduction of T cell replete haploidentical transplantations in a single center
by: Gwendolyn vanGorkom, et al.
Published: (2021-08-01)

Influence of ABO compatibility on haploidentical hematopoietic stem-cell transplant
by: Rajesh B Sawant, et al.
Published: (2023-01-01)

Current status of conditioning regimens in haploidentical hematopoietic cell transplantation
by: Junichi Sugita, et al.
Published: (2024-12-01)

Impact of graft-versus-host disease prophylaxis on immune reconstitution in patients after allogeneic hematopoietic stem cell transplantation
by: E. D. Mikhaltsova, et al.
Published: (2021-11-01)

Haploidentical Hematopoietic Cell Transplantation Using Posttransplant Cyclophosphamide for Sézary Syndrome
by: Madoka Kanda-Kato, et al.
Published: (2020-09-01)

Case report: First report of haploidentical allogeneic hematopoietic stem cell transplantation from donors with mild alpha-thalassemia for acute leukemia
by: Wenshuai Zheng, et al.
Published: (2022-12-01)

Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide for T-Cell Prolymphocytic Leukemia after Alemtuzumab Induction Therapy: A Case Report
by: Naoki Okada, et al.
Published: (2023-08-01)

Haploidentical stem cell transplant: Established treatment, expanding horizons
by: Mukul Aggarwal, et al.
Published: (2016-01-01)

Haploidentical Stem Cell Transplantation With a Novel Conditioning Regimen in Older Patients: A Prospective Single-Arm Phase 2 Study
by: Yu-Qian Sun, et al.
Published: (2021-02-01)

Association between gene polymorphisms in the cyclophosphamide metabolism pathway with complications after haploidentical hematopoietic stem cell transplantation
by: Paula Muñiz, et al.
Published: (2022-09-01)

Is Post-Transplant Cyclophosphamide the New Methotrexate?
by: Alberto Mussetti, et al.
Published: (2021-08-01)

Human Leukocyte Antigen–Haploidentical Haematopoietic Stem Cell Transplantation Using Post-Transplant Cyclophosphamide for Paediatric Haematological Malignancies
by: Takuro Nishikawa
Published: (2024-01-01)

Association of Persistent Minimal Residual Disease with Poor Outcomes of Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
by: Jing Liu, et al.
Published: (2018-01-01)

Repeated haploidentical allogeneic hematopoietic stem cell transplantation with TCR αβ/CD19 depletion in patient with primary myelofibrosis. Case report
by: Elmira I. Kolgaeva, et al.
Published: (2021-07-01)

Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia: a comparative study of the ALWP EBMT
by: Jaime Sanz, et al.
Published: (2020-05-01)

Strategies in Haploidentical Stem Cell Transplantation in Adults
by: Ulaş D. Bayraktar, et al.
Published: (2013-12-01)

Delayed kidney transplantation after HLA-haploidentical hematopoietic cell transplantation in a young woman with myelodysplastic syndrome with renal failure
by: Kevin C. Miller, et al.
Published: (2022-01-01)

Editorial: The Immunobiology of HLA-Haploidentical Hematopoietic Cell Transplantation
by: Antonella Mancusi, et al.
Published: (2020-05-01)

Haploidentical hematopoietic stem cell transplantation in a myelofibrosis patient with primary graft failure
by: Cristina Tecchio, et al.
Published: (2018-01-01)

Post-transplant cyclophosphamide containing regimens after matched sibling, matched unrelated and haploidentical donor transplants in patients with acute lymphoblastic leukemia in first complete remission, a comparative study of the ALWP of the EBMT
by: Jaime Sanz, et al.
Published: (2021-05-01)

Donor specific HLA antibody in hematopoietic stem cell transplantation: Implications for donor selection
by: Scott M. Krummey, et al.
Published: (2022-08-01)

Remission of relapsed/refractory classical Hodgkin lymphoma induced by brentuximab vedotin and pembrolizumab combination after allogeneic hematopoietic stem cell transplantation: a case report
by: Federica Giannotti, et al.
Published: (2024-03-01)

Editorial: Advances in Pediatric Hematopoietic Cell Therapies and Transplantation
by: Emmanuel Katsanis, et al.
Published: (2022-01-01)

Antithymocyte Globulin Plus Post-Transplant Cyclophosphamide Combination as an Effective Strategy for Graft-versus-Host Disease Prevention in Haploidentical Peripheral Blood Stem Cell Transplantation for Children with High-Risk Malignancies
by: Kang-Hsi Wu, et al.
Published: (2022-11-01)

Haploidentical Stem Cell Transplantation in Lymphomas—Expectations and Pitfalls
by: Jacopo Mariotti, et al.
Published: (2020-11-01)

Immune Reconstitution after Haploidentical Donor and Umbilical Cord Blood Allogeneic Hematopoietic Cell Transplantation
by: Hany Elmariah, et al.
Published: (2021-01-01)

Investigation of KIR/HLA relationship and other clinical variables after T-cell-replete haploidentical bone marrow transplantation in patients with acute myeloid leukemia (AML)
by: Tahereh Bakhtiari, et al.
Published: (2023-06-01)

Haploidentical stem cell transplantation with post-transplant cyclophosphamide challenges and outcome from a tertiary care center in Lebanon
by: Jean El Cheikh, et al.
Published: (2023-06-01)

No differences in hemostatic and endothelial activations between haploidentical and matched-donor hematopoietic stem cell transplantation in thalassemia disease
by: Surapong Lertthammakiat, et al.
Published: (2020-09-01)

Refractory cytomegalovirus infections in Chinese patients receiving allogeneic hematopoietic cell transplantation: a review of the literature
by: Donglin Yang, et al.
Published: (2023-12-01)

Features of cytomegalovirus infection and evaluation of cytomegalovirus-specific T cells therapy in children’s patients following allogeneic hematopoietic stem cell transplantation: A retrospective single-center study
by: Yongsheng Ruan, et al.
Published: (2022-10-01)

Increased risk of 100-day and 1-year infection-related mortality and complications in haploidentical stem cell transplantation
by: Chang J, et al.
Published: (2019-05-01)

T-Cell-Replete Versus ex vivo T-Cell-Depleted Haploidentical Haematopoietic Stem Cell Transplantation in Children With Acute Lymphoblastic Leukaemia and Other Haematological Malignancies
by: Katharina Kleinschmidt, et al.
Published: (2021-12-01)

Elafin as a Predictive Biomarker of Acute Skin Graft-Versus-Host Disease After Haploidentical Stem Cell Transplantation Using Post-Transplant High-Dose Cyclophosphamide
by: Laura Solán, et al.
Published: (2021-02-01)

Efficacy and Safety of Unmanipulated Haploidentical Related Donor Allogeneic Peripheral Blood Stem Cell Transplantation in Patients with Relapsed/Refractory Acute Myeloid Leukemia
by: Li-Ping Dou, et al.
Published: (2018-01-01)

Low-dose anti-thymocyte globulin plus low-dose post-transplant cyclophosphamide-based regimen for prevention of graft-versus-host disease after haploidentical peripheral blood stem cell transplants: a large sample, long-term follow-up retrospective study
by: Xingying Li, et al.
Published: (2023-10-01)

Evaluating the Impact of Post-Transplant Cyclophosphamide and Anti-Thymocyte Globulin on CMV Reactivation Following Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Literature Review
by: Jarosław Dybko, et al.
Published: (2023-12-01)